KIDS (orthopediatrics.com) Market Value to Book Value Ratio

orthopediatrics.com (KIDS) - corporate logo

OrthoPediatrics Corp. (KIDS) specializes in developing orthopedic systems for children, facing geopolitical risks and certification complexities during global expansion. Its monopoly position in a niche segment allows the brand to exercise pricing power through premium rates. This chart reflects the stock price dynamics at 1.82. Business resilience is ensured by an extensive pool of certified contractors, which completely mitigates the risk of dependency on specific component manufacturers.

Market Capitalization to Net Assets: orthopediatrics.com (KIDS) for 07/04/2022 - 10/28/2026

KIDS (OrthoPediatrics Corp.): analytical breakdowns and indicator data

- price and consensus price forecast:
Price Chart orthopediatrics.com|KIDS - Analyst Median Target
- market capitalization data:
Market Value OrthoPediatrics Inc.|KIDS - Company Buyout Price
- book capitalization data:
Net Assets per Single Share OrthoPediatrics|KIDS - Net Asset Value|Market Capitalization to Book Value Ratio orthopediatrics.com|KIDS - Company Assets
- debt and liquidity data:
Total Debt to Capital OrthoPediatrics Corp.|KIDS - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital orthopediatrics.com|KIDS - Company Total Debt Obligations|Debts to Book Capitalization OrthoPediatrics Inc.|KIDS - Company Long-Term Debts|Company Short-Term Debt OrthoPediatrics
Initial company analysis:OrthoPediatrics Corp - KIDS
Finished products of OrthoPediatrics Corp.

Logistics disruptions in the delivery of pediatric implants and sanction restrictions directly impact the current market value to book value ratio of OrthoPediatrics Corp. (KIDS). This coefficient is calculated as the quotient of the business's market value divided by the value of its net assets, allowing the investor to isolate price volatility from real changes in capital to assess the fundamental stability of the asset.

Direct competitors

Boston Scientific - Market Value to Book Value Ratio|EW (edwards.com) - Market Capitalization to Book Value|RMD: Market Value to Book Value Ratio|Market Capitalization to Book Value PODD|ZBH - Market Value to Book Value Ratio|Market Capitalization to Net Assets CooperSurgical (COO)|ALGN: Market Capitalization to Book Value Ratio|Market-to-Book Ratio globusmedical.com GMED|TMDX: Market Capitalization to Book Value Ratio|ATEC - Market Cap to Net Assets Ratio|Artivion Inc - Market Capitalization to Book Value Ratio|Enovis Inc. (ENOV) - Market Capitalization to Book Value|IART (Integra LifeSciences) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio ESTA|Market Value to Book Value Ratio Beta Bionics (BBNX)|Market Value to Book Value Ratio IRADIMED Corp (IRMD)|Market Capitalization to Book Value Ratio EMBC|TNDM - Market Capitalization to Book Value|Market Cap to Net Assets Ratio AxoGen, Inc.|SIBN - Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio OFIX|Bioventus Inc (BVS) - Market-to-Book Ratio|Market Capitalization to Book Value Ratio Treace Medical (TMCI)|Capitalization to Book Value Ratio Strata Medical (SRTA)|Carlsmed Inc (CARL) - Market Cap to Net Assets Ratio|Market Value to Book Value RXST (rxsight.com)|ClearPoint Neuro - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Stereotaxis Inc STXS|STIM (NeuroStar) - Market Capitalization to Book Value Ratio|SGHT - Market-to-Book Ratio|Market Capitalization to Book Value Ratio Orchestra BioMed|Anika Therapeutics, Inc. (ANIK) - Capitalization to Book Value Ratio|NSPR: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Jin Medical International Ltd|Market Capitalization to Book Value Ratio VANI (Vivani Medical, Inc.)|Market Cap to Net Assets Ratio xtantmedical.com (XTNT)|Market Capitalization to Book Value Ratio NMTC (NeuroOne Medical Technologies)|Modular Medical Inc - Market Capitalization to Book Value Ratio|MYO - Market Value to Book Value Ratio|Envoy Medical Inc. (COCH) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Vivos Therapeutics, Inc VVOS|enVVeno Corp (NVNO) - Market Value to Book Value|Market Capitalization to Book Value Ratio SINT (Sintx Technologies Inc)|Market-to-Book Ratio TNON|LFWD: Market Value to Book Value Ratio|Market Value to Equity Ratio autonomix.com AMIX|Market Cap to Net Assets Ratio IVF (INVO Bioscience, Inc.)|Market Capitalization to Book Value Ratio Bone Biologics Inc BBLG|Market Capitalization to Book Value Ratio AXNX (Axonics, Inc.)|BIOL: Market Capitalization to Book Value|Market Value to Book Value Ratio dynatronics.com (DYNT)|FNA (Paragon 28) - Market Capitalization to Net Assets|Market Value to Book Value Ratio INVO